Share on StockTwits

Investment Analysts’ new coverage for Wednesday, June 11th:

MLV & Co
began coverage on shares of Arbor Realty Trust (NYSE:ABR). They issued a buy rating and a $9.00 price target on the stock.

Barclays began coverage on shares of Alpha Bank A.E. (NASDAQ:ALBKY). Barclays issued an overweight rating on the stock.

Credit Suisse assumed coverage on shares of Alpha Bank A.E. (NASDAQ:ALBKY). They issued a neutral rating on the stock.

Sanford C. Bernstein assumed coverage on shares of Alder Biopharmaceuticals (NASDAQ:ALDR). The firm issued an outperform rating on the stock.

Bernstein assumed coverage on shares of Alder Biopharmaceuticals (NASDAQ:ALDR). They issued an outperform rating and a $30.00 target price on the stock.

MLV & Co
began coverage on shares of Brandywine Realty Trust (NYSE:BDN). The firm issued a buy rating and a $16.50 price target on the stock. The analysts wrote, “We recently hosted Brandywine management for investor meetings. Our take-aways are as follows: BDN will likely fund growth in the target markets of Philadelphia, Austin and Washington, D.C. with the proceeds from asset sales as it exits non-core markets. Fundamentals remain strongest, with actual rent growth, in Austin, the Philadelphia CBD and the crescent markets of Radnor and Conshohocken – submarkets representing approximately 45% of NOI. “We are increasing our target price to $16.50/sh. Most importantly for the long term, the TEV/SF of $198 is very attractive vs. gross/adjusted replacement cost of $305/$228. This indicates low in-place rents and, hopefully, an ability to grow rents over time.”

National Bank Financial assumed coverage on shares of Brookfield Renewable Energy Partners LP Partnership Units (Bermuda) (NYSE:BEP). The firm issued a sector perform rating on the stock.

NBF assumed coverage on shares of Brookfield Renewable Energy Partners (TSE:BEP.UN). NBF issued a C$33.50 target price on the stock.

Goldman Sachs started coverage on shares of Sothebys (NYSE:BID). The firm issued a neutral rating on the stock.

Barclays initiated coverage on shares of Piraeus Bank Sa (NASDAQ:BPIRY). They issued an equal weight rating on the stock.

Maxim Group assumed coverage on shares of Callon Petroleum Company (NYSE:CPE). They issued a buy rating and a $14.00 price target on the stock.

Bank of America initiated coverage on shares of Devon Energy Corp (NYSE:DVN). Bank of America issued a buy rating and a $100.00 target price on the stock.

BNP Paribas began coverage on shares of Expedia (NASDAQ:EXPE). They issued an outperform rating and a $91.00 price target on the stock.

Wells Fargo & Co. initiated coverage on shares of Hospira (NYSE:HSP). The firm issued a market perform rating on the stock.

Credit Suisse began coverage on shares of Jumei International Holding Ltd(ADR) (NASDAQ:JMEI). Credit Suisse issued a neutral rating and a $33.00 target price on the stock.

GF Securities initiated coverage on shares of Jumei International Holding Ltd(ADR) (NASDAQ:JMEI). They issued a buy rating on the stock.

Wells Fargo & Co. started coverage on shares of Mylan (NYSE:MYL). They issued an outperform rating on the stock.

Barclays started coverage on shares of National Bank of Greece (NYSE:NBG). The firm issued an equal weight rating on the stock.

Credit Suisse assumed coverage on shares of National Bank of Greece (NYSE:NBG). They issued an outperform rating on the stock.

JMP Securities assumed coverage on shares of Ocera Therapeutics (NASDAQ:OCRX). They issued an outperform rating and a $15.00 target price on the stock.

Bank of America initiated coverage on shares of POSCO (NYSE:PKX). Bank of America issued a buy rating on the stock.

Jefferies Group began coverage on shares of Regado Biosciences (NASDAQ:RGDO). Jefferies Group issued a buy rating and a $14.00 price target on the stock.

Compass Point assumed coverage on shares of Unum Group (NYSE:UNM). Compass Point issued a neutral rating and a $38.00 price target on the stock.

BNP Paribas started coverage on shares of Whitbread plc (LON:WTB). BNP Paribas issued an outperform rating and a GBX 5,000 ($84.06) target price on the stock.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.